Cargando…
NPC1 Confers Metabolic Flexibility in Triple Negative Breast Cancer
SIMPLE SUMMARY: Triple negative breast cancer is an aggressive breast cancer subtype with limited targeted therapeutic options. As a method of identifying novel therapeutic targets in this disease subtype, we utilize a microRNA that reverses the Epithelial-to-Mesenchymal Transition, which reveals Ni...
Autores principales: | O’Neill, Kathleen I., Kuo, Li-Wei, Williams, Michelle M., Lind, Hanne, Crump, Lyndsey S., Hammond, Nia G., Spoelstra, Nicole S., Caino, M. Cecilia, Richer, Jennifer K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319388/ https://www.ncbi.nlm.nih.gov/pubmed/35884604 http://dx.doi.org/10.3390/cancers14143543 |
Ejemplares similares
-
Triple Negative Breast Cancer is Dependent on the Lysosomal Cholesterol Transporter NPC1
por: O’Neill, Kathleen
Publicado: (2021) -
OR30-5 Androgen-Regulated Secreted Factors Promote Tumorigenesis and Immune Suppression in Breast Cancer
por: Richer, Jennifer, et al.
Publicado: (2022) -
Reversing an Oncogenic Epithelial-to-Mesenchymal Transition Program in Breast Cancer Reveals Actionable Immune Suppressive Pathways
por: Williams, Michelle M., et al.
Publicado: (2021) -
SAT-145 Cholesterol Uptake as a Critical Vulnerability in Triple Negative Breast Cancer
por: O’Neill, Kathleen
Publicado: (2020) -
Secreted indicators of androgen receptor activity in breast cancer pre-clinical models
por: Hanamura, Toru, et al.
Publicado: (2021)